Subscribe To
Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting
Annual Meeting Reconvened and Adjourned Without Conducting Business Meeting to Reconvene on July 27, 2023 at 9:00 am EDT DEVON, Pa., June 28, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the adjourned 2023 Annual Meeting of […] The post Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting appea...
Read More
Posted: Jun 28 2023, 20:05
Author Name: forextv
Views: 081071